Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-55
SponsorAzienda Ospedaliera Universitaria Integrata Verona
About this trial
The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.
Eligibility criteria
Qualifiers
Age ≤55 years old at the time of diagnosis of pancreatic cancer
Age ≥ 18 years
Written informed consent obtained.
Disqualifiers
Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor)
Absence of informed consent.
Age < 18 years or > 55 years old at the time of diagnosis of pancreatic cancer
Trial design
Treatments tested in this trial
- Register
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov